U.S. Approves Drug Co-Developed by Ugandan Doctor

The U.S. Food and Drug Administration has announced its approval of the Moxidectin 8mg Oral research project which Ugandian health professional Amos Nyathirombo co-founded. The six-year research led by the WHO will help with the treatment of River Blindness in patients 12 years of age and older.

Dr Amos Nyathirombo (left) examines a patient at Gulu Regional Referral Hospital early this year.

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.